We found, on the contrary, that US CVD mortality reduced more rapidly in the late 1970s compared to comparator countries (see online supplementary figure A9).
We found significantly higher mean serum creatinine in the tofacitinib group and it was also in line with a review reporting higher incidence rate of blood creatinine elevation in tofacitinib treatment group compared to comparator group [ 34].
There was a reduction in the percentage of patients sustaining fractures in the active treatment groups compared to comparator group in both studies (8% versus 11%and12%2% versus 13%, resp).; however these reductions did not reach significance.
19 A large meta-analysis showed that weekly exenatide as well as its daily preparation achieved a significant reduction in SBP compared to comparator therapy that included placebo and other hypoglycemic drugs (weighted mean difference =2.22 mmHg; 95% CI =−2.97 to −1.47).
◦ As soon as a benefit in terms of the efficacy of the tested substance compared to the comparator becomes apparent, patients wish to be treated with the new therapy.
As Fig. 4 below shows, in terms of institutional quality factors, compared to other comparator countries, Kosovo is ranked significantly unfavourably.12 If indicators such as rule of law, or control of corruption are compared, for instance to Croatia, scores associated to Kosovo are considerably worse.
The risk of new infection (excluding recrudescences) in DP groups compared to the comparator groups per study and overall result (stratified by study) at Day 28.
The risks of recrudescence (reappearance of the same genotype) in the DP groups compared to the comparator groups (stratified by study), using the different lengths of follow-up of each studies.
The risks of recurrence (defined as recrudescence as above and new infections) in the DP groups compared to the comparator groups (stratified by study), using the different length of follow-up of each studies.
